Pharma

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Most Viewed Abstracts



Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Cytogen Corporation announced that Kevin G. Lokay will immediately assume the position of President and Chief Executive Officer. Mr. Lokay, a member of Cytogen's Board of Directors for the past six years, replaces Michael D. Becker who resigned as an officer and director to pursue another executive position. Mr. Lokay brings more than 26 years of pharmaceutical industry experience to Cytogen's executive management team. Importantly, Mr. Lokay's background includes a strong concentration in the successful sales and marketing of oncology therapeutics and supportive care products


Today in Execs on the Move...keeping you current

Astellas hires new vice president of compliance
Astellas, 09/11/09

Myriad Genetics Elects Louise Phanstiel and Lawrence Best to Its Board of Directors
Myriad, 09/22/09

Sanofi-aventis announces changes to Executive Committee
Sanofi-aventis, 11/04/09

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Send this Summary to a Colleague

Enter email address